Administration of Secretin (RG1068) Increases the Sensitivity of Detection of Duct Abnormalities by Magnetic Resonance Cholangiopancreatography in Patients With Pancreatitis

Background & Aims Administration of secretin improves noninvasive imaging of the pancreatic duct with magnetic resonance cholangiopancreatography (MRCP). We performed a large prospective study to investigate whether synthetic human secretin (RG1068)-stimulated MRCP detects pancreatic duct abnorm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2014-09, Vol.147 (3), p.646-654.e2
Hauptverfasser:	Sherman, Stuart, Freeman, Martin L, Tarnasky, Paul R, Wilcox, C. Mel, Kulkarni, Abhijit, Aisen, Alex M, Jacoby, David, Kozarek, Richard A
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adult Canada Cholangiopancreatography, Endoscopic Retrograde Cholangiopancreatography, Magnetic Resonance Direct Comparison Female Gastroenterology and Hepatology Humans Increasing Resolution Infusions, Intravenous Male Middle Aged Pancreas Pancreatic Ducts - pathology Pancreatitis - diagnosis Pancreatitis - pathology Peptide Hormone Predictive Value of Tests Prognosis Prospective Studies Recurrence Secretin - administration & dosage United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!